Tirzepatide, the innovative medication, is creating considerable excitement within the healthcare community. It functions differently from traditional diabetes medications, targeting both receptors involved in glucose regulation and appetite . Initial trials have demonstrated remarkable efficacy in lowering blood levels in individuals with type 2 d